Literature DB >> 10702638

Function of the p53 gene: choice between life and death.

P M Chumakov1.   

Abstract

Gene p53 is a central component of a system that eliminates pathologically damaged cells from an organism. Multiple signal pathways monitor the state of a cell and when damage or a fault is found that could cause heritable changes, p53 protein is activated to either coordinate the repair process or induce cell suicide. Thus, the p53 gene acts as a supreme judge that decides the fate of cells and guarantees their social behavior. Loss of the p53 gene results in uncontrolled accumulation of genetic damage causing failure of control by the organism, malignant cell growth, and death of the organism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702638

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  5 in total

Review 1.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

Review 2.  [The use of p53 as a tool for human cancer therapy].

Authors:  V P Almazov; D V Kochetkov; P M Chumakov
Journal:  Mol Biol (Mosk)       Date:  2007 Nov-Dec

3.  LASS5 Interacts with SDHB and Synergistically Represses p53 and p21 Activity.

Authors:  Z Jiang; F Li; Y Wan; Z Han; W Yuan; L Cao; Y Deng; X Peng; F Chen; X Fan; X Liu; G Dai; Y Wang; Q Zeng; Y Shi; Z Zhou; Y Chen; W Xu; S Luo; S Chen; X Ye; X Mo; X Wu; Y Li
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

4.  Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells.

Authors:  Xuan Zhang; Ridhwi Mukerji; Abbas K Samadi; Mark S Cohen
Journal:  BMC Complement Altern Med       Date:  2011-10-06       Impact factor: 3.659

Review 5.  Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies.

Authors:  Xun Chen; Ning Duan; Caiguo Zhang; Wentao Zhang
Journal:  J Cancer       Date:  2016-01-10       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.